1.5200
10-January-25 15:16:45
15 minutes delayed
Stocks
-0.1400
-8.43%
Today's range
1.5200 - 1.6499
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 09:00:00 By Nasdaq GlobeNewswire